Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. - Wikidata - awgldk - TriplyDB

Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major.

Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major.

http://www.wikidata.org/entity/Q37442375

about

Evaluation of a new tablet formulation of deferasirox to reduce chronic iron overload after long-term blood transfusions Infiltrative Cardiomyopathies Role of Imaging Techniques for Diagnosis, Prognosis and Management of Heart Failure Patients: Cardiac Magnetic Resonance.Normal values for cardiovascular magnetic resonance in adults and children Role of cardiac MRI in the assessment of nonischemic cardiomyopathies Guidelines on haemovigilance of post-transfusional iron overload Recent advances in cardiac magnetic resonance.MRI Measurements of Iron Load in Transfusion-Dependent Patients: Implementation, Challenges, and Pitfalls Pregnancy in women with thalassemia: challenges and solutions mRNA regulation of cardiac iron transporters and ferritin subunits in a mouse model of iron overload Assessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonance Role of Cardiac MR Imaging in Cardiomyopathies Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing.Review of Journal of Cardiovascular Magnetic Resonance 2012.Review of Journal of Cardiovascular Magnetic Resonance 2011.Comparison of Doppler echocardiographic and tissue Doppler velocity data in beta-thalassaemia major with high and normal NT-proBNP levels of children in the south-east region of Turkey.Longitudinal monitoring of cardiac siderosis using cardiovascular magnetic resonance T2* in patients with thalassemia major on various chelation regimens: a 6-year study.Liver iron content determination by magnetic resonance imaging.Right ventricular volumes and function in thalassemia major patients in the absence of myocardial iron overload.T2 mapping and T2* imaging in heart failure Thalassaemia is a tropical disease.Calibration of myocardial T2 and T1 against iron concentration.International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers.Mapping iron in human heart tissue with synchrotron x-ray fluorescence microscopy and cardiovascular magnetic resonance.Cardiovascular magnetic resonance T2* for tissue iron assessment in the heart.Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overload Low prevalence of fibrosis in thalassemia major assessed by late gadolinium enhancement cardiovascular magnetic resonance Dilated cardiomyopathy with conduction disease and arrhythmia.Value of black blood T2* cardiovascular magnetic resonance.Cardiac iron and cardiac disease in males and females with transfusion-dependent thalassemia major: a T2* magnetic resonance imaging study.Reduced transverse relaxation rate (RR2) for improved sensitivity in monitoring myocardial iron in thalassemia.Iron deposition following chronic myocardial infarction as a substrate for cardiac electrical anomalies: initial findings in a canine model.Iron overload in polytransfused patients without heart failure is associated with subclinical alterations of systolic left ventricular function using cardiovascular magnetic resonance tagging Rapid monitoring of iron-chelating therapy in thalassemia major by a new cardiovascular MR measure: the reduced transverse relaxation rate Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload.On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure.Magnetic resonance comparison of left-right heart volumetric and functional parameters in thalassemia major and thalassemia intermedia patients.Serum Ferritin Levels Correlation With Heart and Liver MRI and LIC in Patients With Transfusion-Dependent Thalassemia.Management of transfusional iron overload - differential properties and efficacy of iron chelating agents.Estimating tissue iron burden: current status and future prospects.

P2860

Q26765306-4C0D9CC3-DF81-405A-BA78-165D497BB354 Q26798533-9441A293-883A-4960-BC45-472B169BCD5F Q26829719-F88843C6-A478-406A-9FB8-29C782A19583 Q26998833-65CA325D-2678-4DED-BBCC-ECDCEEFF3B58 Q26998997-6775392F-53CD-4600-8A08-E98E5D78C4CD Q27022721-A6C63D76-0E2A-4283-B89D-3AAA3BCDB298 Q28066746-8E7C530C-0617-41D0-B991-545F100827C2 Q28072173-8057430B-4740-4A97-873C-77939FE71599 Q28080216-8747C444-8306-45EA-A992-139088A0BDB9 Q28384189-D5A4752C-DEC9-40FD-82E8-F269BE760843 Q28387402-4013143A-9113-4024-ACED-1947D8A4F7F4 Q30279246-563C52B7-E47B-4ABA-AB98-C6DE625D6DD0 Q30418614-888EE6F7-A906-414B-896F-B30F7BD47E84 Q30446298-0BDF000A-8724-4D4A-8A3B-383951BEE671 Q30459937-CE4C60CA-30BA-4CE6-B12E-C231552C9A03 Q31042151-3A845C86-3AD6-48C7-87FD-E39705452000 Q33647638-298D9446-DD5A-44F6-BADB-F0A8E4975B3C Q33764777-976E8144-C6AA-4CD0-9AA0-82FFC89F0C66 Q33843186-3B20CFCC-C2A3-4938-81A2-AEF6EC0F56AA Q33844225-AEB1DC71-8742-4431-84AD-C90425C9A7B1 Q33950343-A0089F87-A077-4698-917D-3ABD8B944D41 Q34091560-C6835706-1975-4337-A5E8-373997F11E87 Q34158260-FE14EE2C-2383-406C-81AE-C2334E584F96 Q34255213-4A7EA353-D6FE-40AA-9F85-BAB2C9B8BF42 Q34422736-73D4CA14-B35C-4DA7-9CF6-2D16F6E7B280 Q34451527-1A48B33B-7A4A-4433-B7E1-074EF0998765 Q34515540-8E505105-4640-4005-BEF9-B86E2609A3ED Q34522622-5C1B7FA7-303E-4424-807B-6FF44A6DF672 Q34706719-B5992928-823C-4E7F-BA37-31B160EF62C2 Q34750508-A4EA4255-12A1-442F-A293-4A3AB191706F Q34992619-43A0ABC9-18DD-475C-A8C1-4193074E3288 Q34996968-55521579-A55C-4D59-A1D7-5397E02587BD Q35027190-9CA50345-F287-4EDC-A7EB-4B1616B8EC79 Q35112908-0B60F76B-B139-4E36-AC9B-799755088934 Q35143774-BA12DA59-BC44-4BC7-B410-0763FEC24124 Q35232747-993FA442-73B2-48E7-8948-A6E54745634B Q35438051-127ECF25-E558-49FE-84B9-281FAD8C4458 Q35644563-46AB6F8E-D3F6-4C94-9212-25C98C3EB526 Q35683841-8959BB2F-DDEA-46C9-97A6-FD570A76380A Q35793545-78A66E54-BA61-4418-963D-B84804A1A516

P2860

Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major.

http://www.wikidata.org/entity/Q37442375

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 October 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cardiac T2* magnetic resonance ...... ications in thalassemia major.

@en

Cardiac T2* magnetic resonance ...... ications in thalassemia major.

@nl

type

label

Cardiac T2* magnetic resonance ...... ications in thalassemia major.

@en

Cardiac T2* magnetic resonance ...... ications in thalassemia major.

@nl

prefLabel

Cardiac T2* magnetic resonance ...... ications in thalassemia major.

@en

Cardiac T2* magnetic resonance ...... ications in thalassemia major.

@nl

P1433

Q37442375-BE2DCEED-E8B4-4116-9D9C-5EACDC363194

P1476

Q37442375-8E58940F-7BB2-411D-9D9A-3C47AD394A77

P2093

Q37442375-2501B13C-8015-4931-9E5B-0D47B75D4945

Q37442375-46725483-23A0-495D-869C-A08853F52A9C

Q37442375-5564AFF3-CFFB-46BD-968E-843CCB533E4D

Q37442375-677415A6-C3B7-40E0-A074-9978D48F6BD1

Q37442375-6D2DBA39-F441-4EDE-BE0B-7D4CD0497F13

Q37442375-89E22FFC-EE21-43F4-AB32-B7139D66C01B

Q37442375-9C2A32BD-A9BB-406F-BE86-5D99DAC75DC4

Q37442375-9D59F52A-D5ED-4290-8920-15F817EBBF92

Q37442375-C9552801-67D4-4D92-B72F-43E18527782C

Q37442375-DFBFF07C-B16C-4D2C-B20F-F82841C9A732

P2860

Q37442375-1B74B7AA-479F-4C10-A8CE-AC29E30C848C

Q37442375-1C896724-847C-4488-92FB-9F437AB7A275

Q37442375-246D947C-1F06-4B3B-BD47-57C229B8996A

Q37442375-32F3556E-1F5D-4F05-8B2B-A7686078099C

Q37442375-42A57A55-EE21-4F8E-9DCC-FC0EC8D841EC

Q37442375-4A688E9C-4585-4542-96E8-25942E8D85DF

Q37442375-52570C7B-87C3-4FDC-BCBD-5B0C067ED33B

Q37442375-550240E1-1AB4-46EC-B67C-7D515B77261D

Q37442375-6F6854D8-10EF-4BEF-8C71-B46417392175

Q37442375-89A35E02-2665-4A98-B81D-1083E81A4E5B

P304

Q37442375-6A54EDC0-60E4-451A-AB71-99637457C010

P31

Q37442375-10C1A594-1F6C-4C7A-B29A-66835939A234

P356

Q37442375-A2A817E1-4B7D-4205-B4F0-3681FFEB25D1

P407

Q37442375-4ED63A9F-2777-4233-A856-4A0B3D3650AD

P433

Q37442375-A77782BF-0203-41DE-BEE8-1CB9D1BD6281

P478

Q37442375-AF1A5E6A-8202-4727-B7B1-B8F9C6882CC1

P577

Q37442375-D03C7F20-6F87-4023-AAF9-5192B5B78804

P698

Q37442375-C46EC506-585F-4FF7-B1DF-8AB531422537

P932

Q37442375-725D655E-2921-4F63-AF09-7B1984FE68F3

P356

CIRCULATIONAHA.109.874487

P1433

P1476

Cardiac T2* magnetic resonance ...... ications in thalassemia major.

@en

P2093

D J Pennell

http://www.w3.org/2001/XMLSchema#string

D Wu

http://www.w3.org/2001/XMLSchema#string

J B Porter

http://www.w3.org/2001/XMLSchema#string

J M Walker

http://www.w3.org/2001/XMLSchema#string

J Patel

http://www.w3.org/2001/XMLSchema#string

J Taylor

http://www.w3.org/2001/XMLSchema#string

L J Anderson

http://www.w3.org/2001/XMLSchema#string

M A Tanner

http://www.w3.org/2001/XMLSchema#string

M A Westwood

http://www.w3.org/2001/XMLSchema#string

M Roughton

http://www.w3.org/2001/XMLSchema#string

P2860

Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1

A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance

ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Dev

MRI detects myocardial iron in the human heart.

Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major.

Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis.

Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy.

Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction.

Longitudinal analysis of heart and liver iron in thalassemia major.

P304

1961-1968

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.109.874487

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19801505

http://www.w3.org/2001/XMLSchema#string

P932

2784198

http://www.w3.org/2001/XMLSchema#string